While CB1 activation contributes to body weight gain and onset of metabolic syndrome, CB2 signaling is thought to mediate contrariwise beneficial effects, aiming at anti-inflammation and reversal of metabolic syndrome [313]. The gene discussed is CNR1; the disease is metabolic syndrome.